Sorry, you need to enable JavaScript to visit this website.
Skip to main content

Search

Astellas Pharma Inc.

US
  • About
    • U.S. Products
      • Medical Safety
        • Safety Data Sheets (v 3.0)
    • Philosophy
      • Charter of Corporate Conduct
    • U.S. Corporate Profile
      • Locations
    • Group Code of Conduct
    • U.S. Leadership
      • Percival Barretto-Ko
      • Joe Devaney
      • Shontelle Dodson
      • Lynn Fenicchia
      • Moyra Knight
      • Mark Reisenauer
      • Steve Sabus
    • Regulations
      • State Regulations
        • California Declaration of Comprehensive Compliance Program
        • Vermont’s Pharmaceutical Marketer Price Disclosure
        • Wholesale Acquisition Cost Information for Colorado Prescribers
      • Consumer Product Safety Commission Regulations
    • Company Facts
      • Astellas Fact Sheet
      • Annual Report
    • Policies & Position Statements
    • Contact Us
    • Procurement
      • Procurement News
      • Prospective Suppliers
      • Existing Suppliers
      • Contact & Resources
      • Authorized Distributors of Records
      • PO terms and conditions
    • Vision & Strategy
    • Governance
    • Political Contributions
    • Ethics & Compliance
    Recommended
    U.S. Corporate Profile

    Learn more about Astellas U.S.

    Read More
  • Innovation
    • Partnering
      • Track Record
      • Areas of Interest
      • Partnering Inquiry
    • R&D
      • Approach
      • Clinical Trials
      • Ethics & Principles
      • Pipeline
    Recommended
    Clinical Trials

    This website provides access to information from Astellas sponsored clinical trials and the purpose is not to promote or advertise any...

    Read More
  • Corporate Responsibility
    • COVID-19 Community Response
    • Commitment To Transparency
      • U.S. Sunshine Act Overview
    • Changing Tomorrow Day
    • Annual Report 2019
    • Corporate Grants
    • Access Accelerated
    • Employee Impact
    • Patient Advocacy
    • Awards & Recognition
    Recommended
    Annual Report 2019

    Steady results as projected for the first year of Strategic Plan 2018.

    Read More
  • News
    • News Releases
      • Stories
      • Corporate
      • Corporate Awards
      • Corporate Social Responsibility
      • Our People
      • Therapeutic Area News
    • The Astellas Way Blog
    • Feature Stories
    • Video Gallery
    • Statements
    • Media Inquiries
    Recommended
    Feature Stories

    Feature Stories showcase the people and programs that bring to life the Astellas Way values and culture.

    Read More

Stakeholders menu

  • COVID-19 Response
  • Patients & Caregivers
    • Support for Patients
      • Astellas Pharma Support Solutions
    • Issues that Matter to You
  • Careers
  • Partnering
  • Contact Us

Common header menu

  • IMPORTANT NOTICE
  • WORLDWIDE
  • US
  • WORLDWIDE - US
  1. Home
  2. About
  3. U.S. Products
  4. Medical Safety
  5. Safety Data Sheets (v 3.0)

Safety Data Sheets (v 3.0)

Important Notice

This website is intended for U.S. residents only. This website contains information about products that may not be available in all countries, or may be available under different trademarks, for different indications, or in different dosages. Nothing contained herein should be considered a solicitation, promotion or advertisement for any drug including those under development. Any information on the products contained herein is not intended to provide medical advice nor should be used as a substitute for the advice provided by your physician or other healthcare provider.

Our Use of Cookies

The site uses cookies to provide you with a more responsive and personalized service and to analyze site traffic. By using this site, you accept our use of cookies as described in our privacy policy. Please read our privacy policy for more information on the cookies we use, the processing of your personal data and how to delete or block the use of cookies.

Accept and Close
logo
You are now leaving www.astellas.com/us. The website you are linking to is neither owned nor controlled by Astellas.
Astellas is not responsible for the content or services on this site.
Cancel Click here to leave this site.

Please click on the product to view SDS information.

ADENOCARD
AMBISOME
ASTAGRAFXL
CRESEMBA CAPSULES
CRESEMBA (ISAVUCONAZONIUM SULFATE) FOR INJECTION
LEXISCAN (REGADENOSON) INJECTION
MYCAMINE (MICAFUNGIN SODIUM) FOR INJECTION
MYRBETRIQ
PADCEV™ (enfortumab vedotin-ejfv) for injection
PROGRAF (TACROLIMUS) GRANULES
PROGRAF CAPSULES
PROGRAF INJECTION
PROTOPIC OINTMENT
TARCEVA
VESICARE
VESIcare LS™ (solifenacin succinate) 1 mg/mL Oral Suspension
XOSPATA TABLETS
XTANDI (ENZALUTAMIDE) CAPSULES
XTANDI (ENZALUTAMIDE) TABLETS

 

About

  • U.S. Products
    • Medical Safety
      • Safety Data Sheets (v 3.0)
  • Philosophy
    • Charter of Corporate Conduct
  • U.S. Corporate Profile
    • Locations
  • Group Code of Conduct
  • U.S. Leadership
    • Percival Barretto-Ko
    • Joe Devaney
    • Shontelle Dodson
    • Lynn Fenicchia
    • Moyra Knight
    • Mark Reisenauer
    • Steve Sabus
  • Regulations
    • State Regulations
      • California Declaration of Comprehensive Compliance Program
      • Vermont’s Pharmaceutical Marketer Price Disclosure
      • Wholesale Acquisition Cost Information for Colorado Prescribers
    • Consumer Product Safety Commission Regulations
  • Company Facts
    • Astellas Fact Sheet
    • Annual Report
  • Policies & Position Statements
  • Contact Us
  • Procurement
    • Procurement News
    • Prospective Suppliers
    • Existing Suppliers
    • Contact & Resources
    • Authorized Distributors of Records
    • PO terms and conditions
  • Vision & Strategy
  • Governance
  • Political Contributions
  • Ethics & Compliance
Astellas LogoAstellas Changing Tomorrow

Follow us on social media

Facebook icon Linkedin icon Twitter icon

Bottom footer menu

  • SITE MAP
  • PRIVACY POLICY
  • ACCESSIBILITY
  • LEGAL DISCLAIMER
  • CONTACT US
© 2020 Astellas Pharma US, Inc.